Shares of Aveanna Healthcare Holdings Inc. (AVAH) surged 9.96% in pre-market trading on Thursday following the company's announcement of better-than-expected first-quarter results and an upward revision to its full-year 2025 guidance.
The home healthcare provider reported Q1 revenue of $559.2 million, significantly beating the analyst estimate of $513.1 million. Adjusted EBITDA came in at $67.4 million, also surpassing expectations of $39.9 million. The company's net income for the quarter stood at $5.2 million, translating to earnings per share of $0.03.
In light of the strong performance, Aveanna raised its full-year 2025 outlook. The company now expects revenue to exceed $2.15 billion, up from the previous guidance range of $2.10 - $2.12 billion. Additionally, the adjusted EBITDA guidance was increased to over $207 million, a substantial boost from the earlier projected range of $190 - $194 million. This positive revision in outlook appears to be a key driver behind the stock's pre-market rally, as investors react favorably to the improved financial prospects for the company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.